Ditchcarbon
  • Contact
  1. Organizations
  2. Lek d. d.
Public Profile
Pharmaceutical Preparation Manufacturing
SI
updated 14 days ago

Lek d. d.

Company website

Lek d.d., a prominent pharmaceutical company headquartered in Slovenia (SI), has been a key player in the industry since its establishment in 1946. With a strong presence in Central and Eastern Europe, Lek d.d. focuses on the development, production, and marketing of generic and innovative medicines, particularly in the fields of oncology, cardiovascular health, and central nervous system disorders. Renowned for its commitment to quality and innovation, Lek d.d. offers a diverse portfolio of products that cater to various therapeutic areas. The company has achieved significant milestones, including its integration into the Sandoz division of Novartis, enhancing its market position and global reach. Lek d.d. continues to be recognised for its contributions to healthcare, making it a trusted name in the pharmaceutical landscape.

DitchCarbon Score

How does Lek d. d.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

45

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

30

Industry Benchmark

Lek d. d.'s score of 45 is higher than 64% of the industry. This can give you a sense of how well the company is doing compared to its peers.

64%

Let us know if this data was useful to you

Lek d. d.'s reported carbon emissions

In 2023, Lek d.d. reported total carbon emissions of approximately 63,453 kg CO2e, comprising 42,900 kg CO2e from Scope 1, 19,070 kg CO2e from Scope 2, and 1,483 kg CO2e from Scope 3 emissions. This marks a significant reduction from 2022, where total emissions were about 92,722 kg CO2e, with Scope 1 at 59,500 kg CO2e, Scope 2 at 26,120 kg CO2e, and Scope 3 at 3,102 kg CO2e. Over the past few years, Lek has demonstrated a commitment to reducing its carbon footprint. In 2021, total emissions were approximately 99,539 kg CO2e, indicating a downward trend in emissions. The company has not publicly disclosed specific reduction targets or initiatives, as indicated by the absence of SBTi or other reduction targets. Lek d.d. is a current subsidiary of Sandoz Group AG, which influences its emissions reporting and climate commitments. The emissions data is cascaded from the parent company, Sandoz Group AG, reflecting the broader corporate sustainability goals. Overall, Lek d.d. is actively working towards minimising its environmental impact, aligning with industry standards for climate action.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

201520162017201820192020202120222023
Scope 1
30,866,000
00,000,000
00,000,000
00,000,000
000,000
000,000
00,000
00,000
00,000
Scope 2
29,613,000
00,000,000
00,000,000
00,000,000
00,000
00,000
00,000
00,000
00,000
Scope 3
30,239,000
00,000,000
00,000,000
00,000,000
0,000
0,000
0,000
0,000
0,000

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Lek d. d.'s primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Lek d. d. is in SI, which has a medium grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Lek d. d. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Johnson And Johnson

US
•
Pharmaceutical Preparation Manufacturing
Updated about 13 hours ago

Hikma Pharmaceuticals

GB
•
Pharmaceutical Preparation Manufacturing
Updated about 13 hours ago

Bristol-Myers Squibb

US
•
Pharmaceutical Preparation Manufacturing
Updated 8 days ago

Astra Zeneca

GB
•
Pharmaceutical Preparation Manufacturing
Updated 8 days ago

Sanofi

FR
•
Pharmaceutical Preparation Manufacturing
Updated 8 days ago

Abbvie

US
•
Pharmaceutical Preparation Manufacturing
Updated 8 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251028.3
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelog
AboutTeamCareersLicense AgreementPrivacy